128 related articles for article (PubMed ID: 31911377)
1. The strength of evidence supporting luteal phase progestogen after assisted reproduction: A systematic review with reference to trial registration and pre-specified endpoints.
Suthaporn S; Jayaprakasan K; Maalouf W; Thornton JG; Walker KF
Eur J Obstet Gynecol Reprod Biol; 2020 Feb; 245():149-161. PubMed ID: 31911377
[TBL] [Abstract][Full Text] [Related]
2. Luteal phase support for assisted reproduction cycles.
van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M
Cochrane Database Syst Rev; 2011 Oct; (10):CD009154. PubMed ID: 21975790
[TBL] [Abstract][Full Text] [Related]
3. WITHDRAWN: Luteal phase support in assisted reproduction cycles.
Daya S; Gunby JL
Cochrane Database Syst Rev; 2008 Jul; (3):CD004830. PubMed ID: 18646113
[TBL] [Abstract][Full Text] [Related]
4. Luteal phase support in assisted reproduction cycles.
Daya S; Gunby J
Cochrane Database Syst Rev; 2004; (3):CD004830. PubMed ID: 15266541
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques.
Farquhar C; Rombauts L; Kremer JA; Lethaby A; Ayeleke RO
Cochrane Database Syst Rev; 2017 May; 5(5):CD006109. PubMed ID: 28540977
[TBL] [Abstract][Full Text] [Related]
6. GnRH agonist during luteal phase in women undergoing assisted reproductive techniques: systematic review and meta-analysis of randomized controlled trials.
Martins WP; Ferriani RA; Navarro PA; Nastri CO
Ultrasound Obstet Gynecol; 2016 Feb; 47(2):144-51. PubMed ID: 25854891
[TBL] [Abstract][Full Text] [Related]
7. Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial.
Griesinger G; Blockeel C; Sukhikh GT; Patki A; Dhorepatil B; Yang DZ; Chen ZJ; Kahler E; Pexman-Fieth C; Tournaye H
Hum Reprod; 2018 Dec; 33(12):2212-2221. PubMed ID: 30304457
[TBL] [Abstract][Full Text] [Related]
8. Oral contraceptive pill, progestogen or estrogen pre-treatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques.
Smulders B; van Oirschot SM; Farquhar C; Rombauts L; Kremer JA
Cochrane Database Syst Rev; 2010 Jan; (1):CD006109. PubMed ID: 20091585
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of progestogen supplementation for luteal phase support in fresh in vitro fertilization cycles.
Mohammed A; Woad KJ; Mann GE; Craigon J; Raine-Fenning N; Robinson RS
Fertil Steril; 2019 Sep; 112(3):491-502.e3. PubMed ID: 31200970
[TBL] [Abstract][Full Text] [Related]
10. Progestogens in luteal support.
Carp HJA
Horm Mol Biol Clin Investig; 2020 May; 42(2):143-148. PubMed ID: 32432564
[TBL] [Abstract][Full Text] [Related]
11. Oral dydrogesterone for luteal phase support in fresh in vitro fertilization cycles: a new standard?
Griesinger G; Blockeel C; Tournaye H
Fertil Steril; 2018 May; 109(5):756-762. PubMed ID: 29778368
[TBL] [Abstract][Full Text] [Related]
12. Estrogen supplementation to progesterone as luteal phase support in patients undergoing in vitro fertilization: systematic review and meta-analysis.
Zhang XM; Lv F; Wang P; Huang XM; Liu KF; Pan Y; Dong NJ; Ji YR; She H; Hu R
Medicine (Baltimore); 2015 Feb; 94(8):e459. PubMed ID: 25715250
[TBL] [Abstract][Full Text] [Related]
13. [Effect of luteal-phase gonadotropin-releasing hormone agonist administration on pregnancy outcome in IVF/ICSI cycles: a systematic review and Meta-analysis].
Yu LP; Liu N; Liu Y
Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):850-858. PubMed ID: 27916070
[No Abstract] [Full Text] [Related]
14. Live birth rates and safety profile using dydrogesterone for luteal phase support in assisted reproductive techniques.
Nadarajah R; Rajesh H; Wong KY; Faisal F; Yu SL
Singapore Med J; 2017 Jun; 58(6):294-297. PubMed ID: 27090598
[TBL] [Abstract][Full Text] [Related]
15. Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction.
Craciunas L; Tsampras N; Coomarasamy A; Raine-Fenning N
Cochrane Database Syst Rev; 2016 May; (5):CD011537. PubMed ID: 27195724
[TBL] [Abstract][Full Text] [Related]
16. Vaginal versus intramuscular progesterone for luteal phase support in assisted reproductive techniques: a systematic review and meta-analysis of randomized controlled trials.
Abdelhakim AM; Abd-ElGawad M; Hussein RS; Abbas AM
Gynecol Endocrinol; 2020 May; 36(5):389-397. PubMed ID: 32054365
[TBL] [Abstract][Full Text] [Related]
17. The effect of luteal-phase support with vaginal progesterone on pregnancy rates in gonadotropin and clomiphene citrate/intra-uterine insemination cycles in unexplained infertility: A prospective randomised study.
Karadag B; Dilbaz B; Karcaaltincaba D; Sahin EG; Ercan F; Karasu Y; Tonyalı NV
J Obstet Gynaecol; 2016 Aug; 36(6):794-799. PubMed ID: 27146108
[TBL] [Abstract][Full Text] [Related]
18. [Study of the effects of three luteal phase supporting strategies on clinical outcomes of intrauterine insemination].
Chi HB; Xin LL; Li R; Chen LX; Li NN
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(23):1830-3. PubMed ID: 27356792
[TBL] [Abstract][Full Text] [Related]
19. Antioxidants for male subfertility.
Showell MG; Mackenzie-Proctor R; Brown J; Yazdani A; Stankiewicz MT; Hart RJ
Cochrane Database Syst Rev; 2014; (12):CD007411. PubMed ID: 25504418
[TBL] [Abstract][Full Text] [Related]
20. Clinical use of progesterone in infertility and assisted reproduction.
Ciampaglia W; Cognigni GE
Acta Obstet Gynecol Scand; 2015 Nov; 94 Suppl 161():17-27. PubMed ID: 26345161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
